ORKA NASDAQ
Oruka Therapeutics, Inc.
1W: -8.2%
1M: -15.8%
3M: +81.5%
YTD: +107.6%
1Y: +452.6%
3Y: +335.1%
5Y: +181.5%
$60.61
+1.92 (+3.27%)
Weekly Expected Move ±10.4%
$49
$55
$62
$68
$75
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026203
Institutions Holding
+51 vs prior
92.9%
Ownership
+23.18%
59
New
56
Increased
63
Reduced
37
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 700 | $61.16 | $43K | Filing |
| 2026-05-18 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 800 | $60.34 | $48K | Filing |
| 2026-05-18 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 4,600 | $59.19 | $272K | Filing |
| 2026-05-18 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 4,190 | $58.34 | $244K | Filing |
| 2026-05-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 100 | $63.52 | $6K | Filing |
| 2026-05-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 2,100 | $62.42 | $131K | Filing |
| 2026-05-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 4,800 | $61.56 | $295K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 2,200 | $62.58 | $138K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 1,800 | $64.15 | $115K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 300 | $65.10 | $20K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 400 | $66.06 | $26K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 200 | $67.16 | $13K | Filing |
| 2026-05-01 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 100 | $68.48 | $7K | Filing |
| 2026-04-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 4,227 | $65.73 | $278K | Filing |
| 2026-04-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 2,273 | $66.56 | $151K | Filing |
| 2026-04-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 500 | $67.38 | $34K | Filing |
| 2026-03-02 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 2,675 | $33.81 | $90K | Filing |
| 2026-03-02 | Sandler Laura Lee | officer: chief operating officer | S-Sale | 2,325 | $33.28 | $77K | Filing |
| 2026-02-17 | Goncalves Joana | officer: chief medical officer | S-Sale | 6,064 | $32.30 | $196K | Filing |
| 2026-02-17 | Goncalves Joana | officer: chief medical officer | S-Sale | 936 | $32.78 | $31K | Filing |
| 2026-01-23 | Sandler Laura Lee | officer: chief operating officer | A-Grant/Award | 32,500 | $— | $0 | Filing |
| 2026-01-23 | Quinlan Paul T | officer: general counsel | A-Grant/Award | 32,500 | $— | $0 | Filing |
| 2026-01-23 | Klein Lawrence Otto | officer: chief executive officer | A-Grant/Award | 76,700 | $— | $0 | Filing |
| 2026-01-23 | Dambkowski Carl | director | J-Other | 116,483 | $— | $0 | Filing |
| 2026-01-23 | Agarwal Arjun | officer: svp, finance | A-Grant/Award | 17,500 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 7,431,403 | $365M | +170,019 | 2026-03-31 | Filing |
| Fairmount Funds Management LLC | 3,705,262 | $182M | — | 2026-03-31 | Filing |
| BlackRock, Inc. | 3,527,087 | $173M | -12,328 | 2026-03-31 | Filing |
| VIKING GLOBAL INVESTORS LP | 2,666,690 | $131M | — | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 2,320,316 | $114M | +610,000 | 2026-03-31 | Filing |
| RTW INVESTMENTS, LP | 2,058,148 | $101M | — | 2026-03-31 | Filing |
| Deep Track Capital, LP | 2,034,203 | $100M | -127,307 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,859,631 | $91M | +1,859,631 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,613,461 | $79M | +229,614 | 2026-03-31 | Filing |
| Remedium Capital Partners, LLC | 1,565,661 | $77M | +13,247 | 2026-03-31 | Filing |
| Avidity Partners Management LP | 760,424 | $52M | +100,000 | 2026-03-31 | Filing |
| Polar Capital Holdings Plc | 1,047,693 | $51M | +69,405 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 1,004,056 | $49M | +65,635 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 954,867 | $47M | +12,360 | 2026-03-31 | Filing |
| Woodline Partners LP | 574,882 | $28M | +329 | 2026-03-31 | Filing |
| Cormorant Asset Management, LP | 533,340 | $26M | — | 2026-03-31 | Filing |
| Affinity Asset Advisors, LLC | 499,673 | $25M | -302,669 | 2026-03-31 | Filing |
| Synergy Asset Management, LLC | 476,196 | $23M | +17,250 | 2026-03-31 | Filing |
| SR One Capital Management, LP | 430,330 | $21M | — | 2026-03-31 | Filing |
| Candriam S.C.A. | 411,006 | $20M | +10,497 | 2026-03-31 | Filing |